Natixis Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$718M Buy
780,730
+52,279
+7% +$53M 1% 14
2025
Q4
$783M Buy
728,451
+27,789
+4% +$26.6M 1.11% 13
2025
Q3
$535M Buy
700,662
+68,590
+11% +$51M 0.78% 19
2025
Q2
$493M Sell
632,072
-13,774
-2% -$10.7M 0.78% 19
2025
Q1
$533M Buy
645,846
+84,977
+15% +$70.7M 0.99% 11
2024
Q4
$433M Buy
560,869
+30,156
+6% +$25M 0.81% 17
2024
Q3
$470M Sell
530,713
-335
-0.1% -$301K 0.92% 11
2024
Q2
$481M Sell
531,048
-634
-0.1% -$507K 1.05% 10
2024
Q1
$414M Buy
531,682
+24,536
+5% +$17.5M 0.95% 11
2023
Q4
$296M Buy
507,146
+32,690
+7% +$19.1M 0.78% 16
2023
Q3
$255M Sell
474,456
-44,719
-9% -$23M 0.78% 14
2023
Q2
$243M Buy
519,175
+25,419
+5% +$10.7M 0.75% 17
2023
Q1
$170M Sell
493,756
-803
-0.2% -$271K 0.58% 24
2022
Q4
$181M Buy
494,559
+56,495
+13% +$20M 0.68% 17
2022
Q3
$142M Buy
438,064
+13,808
+3% +$4.37M 0.6% 22
2022
Q2
$138M Buy
424,256
+35,995
+9% +$10.8M 0.6% 17
2022
Q1
$111M Buy
388,261
+165,469
+74% +$42.6M 0.42% 44
2021
Q4
$61.5M Buy
222,792
+34,025
+18% +$8.63M 0.24% 99
2021
Q3
$43.6M Buy
188,767
+13,495
+8% +$3.33M 0.18% 136
2021
Q2
$40.2M Buy
175,272
+23,367
+15% +$4.69M 0.19% 133
2021
Q1
$28.4M Buy
151,905
+21,044
+16% +$4.12M 0.15% 170
2020
Q4
$22.1M Buy
130,861
+5,233
+4% +$781K 0.13% 192
2020
Q3
$18.6M Sell
125,628
-10,144
-7% -$1.57M 0.12% 207
2020
Q2
$22.3M Buy
135,772
+10,833
+9% +$1.66M 0.15% 169
2020
Q1
$17.3M Buy
124,939
+39,182
+46% +$5.38M 0.14% 166
2019
Q4
$11.3M Buy
85,757
+5,163
+6% +$598K 0.08% 289
2019
Q3
$9.01M Buy
80,594
+9,941
+14% +$1.11M 0.07% 303
2019
Q2
$7.83M Sell
70,653
-3,808
-5% -$448K 0.06% 332
2019
Q1
$9.66M Buy
74,461
+4,864
+7% +$591K 0.08% 269
2018
Q4
$8.05M Buy
69,597
+15,037
+28% +$1.68M 0.08% 276
2018
Q3
$5.86M Buy
54,560
+8,011
+17% +$801K 0.05% 407
2018
Q2
$3.97M Buy
46,549
+6,376
+16% +$524K 0.04% 545
2018
Q1
$3.11M Sell
40,173
-2,315
-5% -$186K 0.03% 608
2017
Q4
$3.59M Buy
42,488
+2,908
+7% +$247K 0.04% 522
2017
Q3
$3.38M Sell
39,580
-1,491
-4% -$122K 0.04% 564
2017
Q2
$3.38M Buy
41,071
+3,715
+10% +$303K 0.04% 554
2017
Q1
$3.14M Sell
37,356
-53
-0.1% -$4.25K 0.03% 573
2016
Q4
$2.75M Sell
37,409
-48,238
-56% -$3.59M 0.03% 588
2016
Q3
$6.87M Sell
85,647
-1,145
-1% -$91.6K 0.09% 278
2016
Q2
$6.83M Sell
86,792
-3,199
-4% -$241K 0.09% 266
2016
Q1
$6.48M Buy
89,991
+4,984
+6% +$377K 0.1% 256
2015
Q4
$7.16M Sell
85,007
-3,951
-4% -$328K 0.12% 223
2015
Q3
$7.45M Buy
88,958
+18,463
+26% +$1.56M 0.13% 207
2015
Q2
$5.89M Buy
70,495
+9,807
+16% +$747K 0.1% 278
2015
Q1
$4.41M Buy
60,688
+1,582
+3% +$113K 0.08% 402
2014
Q4
$4.08M Sell
59,106
-6,194
-9% -$418K 0.08% 405
2014
Q3
$4.24M Sell
65,300
-28,188
-30% -$1.78M 0.09% 365
2014
Q2
$5.81M Buy
93,488
+11,812
+14% +$705K 0.08% 384
2014
Q1
$4.81M Buy
81,676
+6,547
+9% +$365K 0.07% 425
2013
Q4
$3.83M Buy
75,129
+47,806
+175% +$2.39M 0.06% 464
2013
Q3
$1.38M Buy
27,323
+1,299
+5% +$68K 0.03% 627
2013
Q2
$1.28M Buy
+26,024
New +$1.42M 0.03% 626

Other funds holding LLY

Natixis Advisors's LLY Position: Q1 2026 in Review

Natixis Advisors increased its Eli Lilly (LLY) stake by 7.2% in Q1 2026, buying an estimated $53M and bringing the position to 780,730 shares worth $718M. The position accounts for 1% of the portfolio, ranked #14.

Natixis Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $783M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Natixis Advisors held 780,730 shares of Eli Lilly worth $718M as of Q1 2026.
  • Natixis Advisors bought 52,279 Eli Lilly shares in Q1 2026, an estimated $53M.
  • Eli Lilly made up 1% of Natixis Advisors's portfolio in Q1 2026, its #14 holding.
  • Natixis Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Natixis Advisors's Eli Lilly position peaked at $783M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.